D-0108-2018 Class III Terminated
FDA drug recall D-0108-2018 was initiated by Teva Pharmaceuticals USA on Nov 28, 2017 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: high out of specification test results obtained for individual and total impurities. The recall status is terminated (terminated Jul 3, 2018). Affected quantity: 42,384 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 20, 2017
- Initiation Date
- Nov 28, 2017
- Termination Date
- Jul 3, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 42,384 bottles
Product description
Penicillin V Potassium for Oral Solution, USP, 125 mg (200,000 U) per 5 mL, 100 mL (when mixed) bottle, Rx only, Manufactured In Canada By: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454; NDC 0093-4125-73.
Reason for recall
Failed Impurities/Degradation Specifications: high out of specification test results obtained for individual and total impurities.
Distribution pattern
Nationwide in the USA and Puerto Rico.
Code information
Lot # 35433115A, Exp 01/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0108-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026